➡️ Back to the main consultation page.
UNDP values your insights and experiences. Please feel free to share your work and comments in whichever format you prefer. You don’t need to address all the guiding questions—they are provided simply to guide our discussion. |
The International Guidelines on Human Rights and Drug Policy, launched in late 2019, represent a landmark effort to support UN Member States in designing and implementing evidence-based, public health-oriented drug policies grounded in international human rights law. Developed through a participatory process led by UNDP, International Centre on Human Rights and Drug Policy WHO, UNAIDS, and OHCHR, the Guidelines provide a comprehensive and practical framework for reforming drug laws and policies in a manner that protects health, upholds human dignity, and advances human rights for all—especially for those most affected by punitive, exclusionary, and criminalizing approaches.
In 2025, the CND approved a Resolution led by Colombia, focusing on strengthening the global drug control system and enhancing the implementation of international drug policy commitments under the UN drug control conventions. Expressing concern over continuing gaps—such as rising overdose deaths, illicit cultivation, and drug-related violence—the resolution reaffirms the need for full implementation of existing treaty obligations while enabling flexible, context-specific national responses. Central to this proposal is the creation of a 20-member independent expert panel, composed of individuals nominated by UN bodies, including the Commission, the Secretary-General, the INCB, and the WHO. The panel is expected to conduct wide-ranging consultations and provide concrete recommendations, with progress reported in 2026 and final proposals to be discussed in 2027, informing the 2029 global drug policy review. Implementation will depend on extrabudgetary resources, with Member States and donors encouraged to contribute.
This resolution presents important windows of opportunity for strengthening rights-based, inclusive, and development-oriented drug policy work innternationaly, including with the usage of the International Guidelines.
Guiding questions:
- In your experience, how have UNDP-supported initiatives engaged with the Guidelines or broader drug policy reform?
- What are the most urgent human rights concerns related to drug policy in your community or sector?
- How can UNDP better support inclusive, rights-based approaches to drug policy—particularly for marginalized or criminalized populations?
- What recommendations would you offer UNDP to strengthen its work in this area?
- How can UNDP and other UN partners ensure meaningful participation of affected communities in policy development and implementation?
- What tools, partnerships, or approaches have been most effective in advancing reform?
- What recommendations do you have for the expert group to better have an impact on lived realities on the ground?
How to contribute?
💬 Use the comment section below to share your perspective.
✍️ Please introduce yourself when responding for the first time.
📌You can tag moderators and contributors by adding 👉 @ 👈 in front of their names, you can attach relevant background documents and examples by clicking on “Add attachment”.
↩️ Please indicate the question number(s) in your response!
Any technical issues can be shared with: [email protected]. Any other questions about this consultation can be addressed to: [email protected].
---
Comments (16)
I don't have enough knowledge to answer
I'll say some that are more "close to me" and my context:
- Systematic exlusion/tokenism of people who use drugs (even worst in the case of young people) in decision making spaces;
- Lack of services outside of the scope of the "traditional drug user" (injected drug use, opioids, men, old, etc, especially when our reality nowadays is so different);
- Constant emergence of NPS due to prohibiotionism that puts PWUD in more danger in all possible ways;
- Lack of options for people who use stimulants (such as pharmological options that are having good results in some countries/contexts);
- The categories/binaries that continue to divide us instead of uniting us, like good vs bad drug, or good vs bad drug user, also "functional", "recreational", "problematic", etc, that end up "othering" and stimatizing more the "others"
- Lack of concern or focus on structural, political and social determinants of health
- Institutional violence, from services, and professionals and overall stigma;
- Standartized and abstinence-only "treatment" options, that exclude a lot of people
3, 4, 5. Include PWUD with different backgrounds and listen and allow for co-leadership
6. Not sure if the "correct" answer but civil disobedience? Advocacy of peer-led orgs. Also, unfortunately that this is necessary but "emergencies" and "crisis" like HIV, COVID... And funding of course. And not giving up :)
7. Listen to people, validate lived and LIVING expertise
8. Again, it would be amazing (and crucial) that it includes PWUD, or at least meaningfully "consult" them in the process and use that data. Take into account human rights (also the Guidelines, for example). Be transparent regarding the process and what is being done and why, create concrete recommendations, focus on everything I already mentioned (and many other things that I'm not covering and are important)
Thank you so much, Teresa Castro, for putting all of this together. It takes real courage and clarity to articulate these issues so comprehensively, especially the solutions around co-leadership and human rights.
You highlighted the systematic exclusion/tokenism of PWUD, particularly young people, in decision-making spaces, contrasting this with the crucial need for co-leadership and the validation of lived and living expertise.
This raises a vital question: we often talk about "consulting" or "involving" PWUD, but how do we move beyond that initial, often superficial, step toward authentic co-design and co-governance of services and policies? What are the biggest, most concrete barriers you’ve seen that prevent peer leaders from actually holding power and directing funding? Is it often a lack of funding for peer-led organisations, or is it a deeper, institutional unwillingness to cede control?
Thank you again for such a stimulating and challenging set of observations.
Ricky Gunawan
Hello Ricky! Thank you! I'll talk about my personal experience:
first of all, I feel that even in the harm reduction field, it is not common to see people who publicly state using drugs (I mean, actually currently using and stating that publicly, not only people who USED in the past, or are in agonist treatment, or "recovered", etc. not that their voices don't matter, they do of course, but cannot be the only ones "included"). Even in big and important HR orgs this happens. And I totally understand why, I am not blaming anyone. I know the real life cnsequences of doing it, and we absolutely must protect ourselves. But it seems that we are always talking about "the others". The people who use drugs, the young people who use drugs, the women who use drugs, while advocating at the same time that those should be the ones included in discussions. It seems contradictory. Not sure I make sense. And at the same time, it "alienates" and scares those who actually use drugs from talking about it because they feel alone. I do feel that many times and it's uncomfortable, scary. But then you also have to consider the context and whether being open about it is going to be positive. It's confusing... I think it's very necessary for people to assume it, but I totally understand why they don't. And then most who do it (myself included) are in a somewhat privileged condition that "allows" them to do it (which still does not remove all the negative consequences that come with it, but decreases the severty), and do we want only privileged people talking? And some decision making spaces are very formal and unconfortable, at least for me, and I am used to formal contexts due to my work, so I can imagine how it might be for other people.
Another thing is of course funding. And not paying and validating people who use drugs' expertise the same way other profissionals are valued and paid. And the entire process itself excludes the most marginalized (like having to "talk" and "understand" bureaucreatic language, having to be available in specific times, traveling to specific places, while being criminalizaed and having to deal with marginalizion and its consequences as barriers that impede you from participating in this type of processes...)
Yes I also think there is unwillingness to give up some of that power to the communities that are affected by the decisions from those holding the power. The decisions are made for those who hold the power and not those who should benefit from it.
Again, I hope I have answered your questions!
Teresa Castro thank you for sharing this so honestly. This makes sense! And yes, there’s a real contradiction in our field: we say we want to centre people who use drugs, but when someone is open about current use, the risks and stigma make it incredibly hard. That silence isn’t always about lack of willingness, but more often it’s about protection and survival, and you named that clearly.
And of course, the reality around privilege, access, language, and being recognised and paid for expertise is a huge part of it. I think we don't talk that much. Appreciate you voicing this. It’s an important reminder of how much work there still is to make participation genuinely safe and equitable.
Ricky Gunawan It's like criminalization creates these barriers that exlude the most marginalized communities of people who use drugs from participating in any way whatsoever in these processes, because when your daily reality is based in dealing with negative consequences of prohibitionism, you are living in survival mode. This makes it impossible for many people to have mental capacity, time, energy, even interest (because your priority is survival, of course) to participate even in the most basic ways or making yourself visible and known. Am I making sense? And then they are considered "too chaotic" or "unstable" to participate, or "uninterested" in doing it, when this is the result of a systemic vicious cicle and not a free personal choice. I'm sorry I'm just giving more problems and not actually solutions
Criminalisation doesn’t just punish. It shuts people out of the very spaces that claim to represent them. When someone is in survival mode, participation becomes a luxury the system hasn’t earned the right to expect. No need to apologise! Naming the problem is part of the work. We don’t solve structural issues by pretending they’re simple. Thanks again for sharing!
Hi! Happy to see the vibrant discussion here! Sharing some more experiences from Youth RISE again and our efforts to "break into" traditional policymaking spaces to move beyond tokenistic inclusion/participation.
The International Guidelines on Human Rights and Drug Policy has been an important document informing and supporting our work, as it highlights clear obligations for States to ensure that people who use drugs’s dignity, rights, and specific needs are fully respected in all aspects of drug policy. Drawing in particular on the section on youth, our advocacy, programming, and peer-led approaches are centered on advancing youth participation, safeguarding access to non-discriminatory, youth-friendly harm reduction services, and consistently foregrounding the right to health, protection, and development for all young people—regardless of their involvement with drugs.
But this has not been easy. Our network stands at a pivotal moment, navigating severe funding constraints and growing divides in the global landscape. These challenging times underscore the urgency of amplifying the voices of young people in drug policy, advocacy, and evidence-building, and reinforcing coalitions for Full Spectrum Harm Reduction.
Despite increasing challenges, our team of 31 members, with global representation — 17 from the Global South and 14 from the Global North — has continued to grow. Over the past two years, we’ve held 2 Annual Strategy Meetings, produced 15 publications, contributed to 12 international conferences and 11 United Nations (UN) engagements, and hosted 6 global workshops and webinars that brought together young people, key community stakeholders and policymakers.
We know that Young People Who Use Drugs and young people otherwise affected by drug policies hold the keys to a more just and equitable world that truly leaves no one behind, and we will continue to channel our collective energy towards this aim.
Current evidence shows young people make up one of the largest demographics of people who use drugs, and they face disproportionate health risks, such as HIV, Hepatitis C, and fatal overdose. Access to relevant harm reduction services is still unavailable for most, even as some leading UN bodies and governments begin to acknowledge these gaps. Youth and adolescents require innovative, inclusive, and stigma-free services tailored to their needs—including privacy protections and flexible age of consent policies. For instance, members in Algeria have combined sports and harm reduction education to create safe and stigma-free learning spaces.
Youth RISE continues its efforts to place youth-friendly harm reduction at the center of debates on drug policy, health, and human rights. In the past two years, we have:
There is growing recognition that punitive drug policies disproportionately violate young people’s human rights through over-policing, criminal ‘justice’ approaches to drug use, possession, cultivation and trade, criminal records that hinder access to jobs, housing, education and social supports, and early justice-system contact that damages mental health and erodes trust in law enforcement.
Youth RISE brought young people’s experiences into international spaces, such as the Commission on Narcotic Drugs,and into landmark reports such as the 2023 Office of the High Commissioner for Human Rights (OHCHR) Report. We advised policymakers on centering young people in drug policy, presenting models of decriminalisation and regulation, including at the Amsterdam Conference: Dealing with Drugs with city-level policymakers worldwide.
Harm reduction services and community networks of People Who Use Drugs are facing existential challenges ranging from critical funding withdrawals in Africa and Asia (due to The United States President's Emergency Plan for AIDS Relief [PEPFAR] funding cuts) to repressive foreign agent laws expanding across the Eastern Europe and Central Asia region, which as of 2024, have been adopted in Belarus, Kyrgyzstan, Georgia, Russia and Tajikistan.
In response, Youth RISE has spent the past 2 years creating frameworks, resources, and tools for Full Spectrum Harm Reduction. We work to ensure that, as our movement regains stability in funding, Young People Who Use Drugs are meaningfully engaged in decision-making regarding funding for harm reduction services. For example, through the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) Elevating Youth Voices project,Young People Who Use Drugs in 8 Global South countries were trained on Global Fund processes and how to influence national funding decisions and advocate for Full Spectrum Harm Reduction approaches in national policies and practices. Further, throughout 2023 and 2024, we provided 28 small grants to support projects from our worldwide membership that enable harm reduction provision and ensure drug policies support — instead of punishing — young people. For example, through these small grants, dialogue and discussion spaces with the general public, decision-makers, press, religious leaders, law enforcement, harm reduction experts, civil society, activists, and Young People Who Use Drugs in Pakistan, Nigeria, Indonesia and Uganda.
Youth RISE is currently developing a Full Spectrum Harm Reduction Toolkit and advocacy curriculum to equip young advocates with the necessary tools for promoting stigma-free drug education and advancing meaningful youth engagement in decision-making for drug policy reform. We hope this tool will support the strengthening of local policy reform efforts aligned with the international guidelines and advanced by and with young people.
We have been working hard, but the meaningful co-design of policies and services is also heavily conditioned by political will, which tends to be a difficult topic whenever we bring drugs and young people in the same sentence. Together with the Global Commission on Drug Policy, we are currently conducting a global study scoping this issue and trying to understand how punitive drug policies - usually disguised as efforts to "protect the children" - impact children and youth. The research is based on global consultations bringing together actors from CSOs, government, and international organizations working in different fields connected with drug policy, children and youth rights, health, and human rights. The study is also conducting consultations with children and youth putting special care in centering the experiences of those most impacted by current policies. We will be publishing a policy brief in early 2026 that presents the results of this research, and we hope this will be a tool that initiates a long-overdue conversation on the impacts of drug policies on younger generations and creates the political will to address the topic using children and human rights frameworks
.
Dear Rebeca Marques Rocha,
Thank you very much for this rich and inspiring contribution, and for sharing Youth RISE’s extensive experience in promoting meaningful youth engagement and rights-based approaches in drug policy reform. Your reflections on the challenges and achievements of young people breaking into traditional policymaking spaces provide valuable insights for this discussion. Specifically, it is important to learn about your work on full-spectrum harm reduction.
To help deepen the dialogue and connect your experiences to our broader objectives, we would appreciate it if you could expand a bit more on the recommended priorities for strengthening young people’s involvement in drug policy reform in countries where YouthRISE is working.In particular, it would be helpful to hear your perspectives on specific of better using UNDP and other UN bodies to support your organisation and it's members in your importnant work. How could UNDP better support inclusive and rights-based approaches, especially for young people and other criminalized populations What are your practical recommendations to UNDP and other UN partners to ensure the meaningful participation of affected communities in policy design and implementation?
Your insights on these points would be very valuable in shaping collective recommendations and ensuring that youth voices remain central to the global human rights and drug policy agenda.
At Ado Reporters Africa (ADRA), we consider the International Guidelines as key references for shaping inclusive, rights-based, and community-centered drug policies. In Africa, local communities face complex sociocultural and economic realities, which require nuanced approaches beyond punitive frameworks.
Our experience working with young people, women, and marginalized groups shows that community engagement, education, and empowerment are critical for effective and sustainable drug policies. Grassroots feminist and youth-led organizations are uniquely positioned to bridge the gap between global policy ambitions and the realities on the ground.
We urge UNDP to strengthen its partnerships with civil society actors like ADRA, ensuring that policies are informed by lived experiences, cultural contexts, and social justice principles, and that affected communities are genuinely empowered rather than criminalized.
Dear ADRA colleagues,
It would be very interesting to learn in more detail how you are applying the Guidelines in your practical work — particularly in the context of advocacy or program development. Could you please share a bit more about how these principles or recommendations are being used in your daily practice or within your organization’s activities? Any specific examples or lessons learned would be greatly appreciated, as they could be very valuable for our shared learning and future collaboration.
PERLE SOCIALE encourages UNDP to deepen its collaboration with grassroots and feminist organizations in Africa to operationalize the Guidelines at the community level. The UNDP’s leadership can be decisive in promoting gender-responsive, youth-led, and evidence-based reforms, especially in rural contexts where women and young people face intersectional discrimination. The organization recommends that UNDP use the Guidelines to (a) mainstream human rights and gender equality in all drug policy programs, (b) ensure the participation of affected populations, including rural youth and women, in policy dialogue, and (c) integrate drug policy reform into the Sustainable Development Goals framework, particularly SDGs 3, 5, 10, and 16. By aligning its interventions with these principles, UNDP can help governments move from criminalization to empowerment, fostering dignity and equity for all affected communities.
Dear PERLE SOCIALE colleagues,
Thank you very much for your valuable suggestions. You have very rightly highlighted the key strategic directions for applying the Guidelines — namely:
(a) mainstreaming human rights and gender equality across all drug policy programs,
(b) ensuring the meaningful participation of affected populations, including rural youth and women, in policy dialogue, and
(c) integrating drug policy reform within the broader Sustainable Development Goals framework, particularly SDGs 3, 5, 10, and 16.
I would like to kindly ask if you could share any practical suggestions on how these directions could be further implemented at the country and regional levels. In your view, what could be most effective for UNDP and other stakeholders to focus on? For example, should the emphasis be placed on educational and capacity-building activities — perhaps for civil society, or for specific groups of government stakeholders such as judges, prosecutors, or law enforcement officers? Or would you see more value in joint policy initiatives and collaborative actions developed together with community representatives and affected populations?
Your insights and examples would be extremely helpful for shaping our next steps and identifying the most practical ways to advance the use of the Guidelines in different contexts.
Dear Ganna Dovbakh,
Thank you sincerely for your interest in learning more about how we apply the International Guidelines on Human Rights and Drug Policy in our daily practice. These Guidelines serve as a living framework for our advocacy, program design, and governance, guiding our commitment to inclusive, rights-based, and community-driven approaches in contexts where social stigma, gender inequality, and punitive traditions remain deeply rooted.
In our advocacy work, the Guidelines are at the heart of our community dialogues and public engagements. Through our civic initiative “Wéndia Dotomi” (Young girl: listen to me), we bring together youth, women, traditional and religious leaders, and local authorities to discuss sensitive issues such as drug use, gender norms, and social exclusion. These dialogues help shift local narratives from punishment to protection and from stigma to support. They also produce local action notes and commitments signed by participants, which we later use in our municipal advocacy. Through these processes, we translate the human rights principles of the Guidelines into community language, making them accessible, practical, and culturally meaningful.
In program implementation, we integrate the Guidelines across our initiatives on education, health, and social resilience. Our field teams in Savalou and Abomey-Calavi conduct community-based activities that combine awareness, capacity building, and livelihood support. For instance, during our “Street Clinics for Reproductive Rights”, we provide mobile awareness sessions on sexual and reproductive health while addressing stigma against women and youth who use substances. Our harm reduction approach is strengthened by peer education modules and by collaboration with local partners such as the ABPF. We also develop small-scale livelihood initiatives like vocational and digital entrepreneurship training for young women and marginalized youth to provide genuine alternatives to exclusion and economic dependency. This approach aligns with the Guidelines’ vision of sustainable and human-centered development.
Our governance and internal culture are equally inspired by the Guidelines. ADRA operates under a feminist and inclusive governance model led by a five-woman coordination team. All decision-making processes are participatory, ensuring that young people, women, and marginalized voices including LGBTQI+ persons and persons with disabilities contribute equally. We have established internal conduct protocols that guarantee safety, confidentiality, and respect in all activities. Every program is validated by a local consultative group composed of community representatives who ensure that interventions remain relevant and grounded in lived realities.
Documentation and accountability are central to our practice. Through our RADAR (Réseau d’Alerte et de Documentation des Attaques contre les Résistances anti-droits) system, we collect testimonies and field data that reveal how punitive drug responses intersect with gender-based violence, discrimination, and rights violations. These findings feed into our advocacy briefs and policy notes submitted to local authorities and national decision-makers. They also inform our regional collaborations with feminist and youth-led networks within the WHRIN (Women Human Rights Defenders International Network) that share our vision of a humane and equitable drug policy.
A key lesson we have learned is that human rights principles only create change when communities recognize themselves in them. We therefore invest time and creativity in localizing the Guidelines through storytelling, radio broadcasts in local languages, and participatory visual media. This makes abstract policy principles tangible and relevant. As a result, we have observed encouraging changes: traditional leaders now refer affected youth to social services rather than to punitive mechanisms, local health workers have begun integrating inclusive service protocols after joint training sessions, and young women beneficiaries of our livelihood projects report increased autonomy and community acceptance.
In short, for ADRA, applying the Guidelines is not a theoretical exercise but a continuous process of translation, co-creation, and accountability. It shapes how we design, implement, and govern our work. We would be very glad to continue this exchange, share our practical tools and methodologies, and explore how our experience could contribute to UNDP’s collaborative learning and policy efforts.
Geraude Maribelle ADOUKONOU
President
Ado Reporters Africa (ADRA)
girlsandyouthconnected.com
[email protected]
Dear Geraude Maribelle,
Thank you very much for sharing your practical experience in such valuable detail. Your contribution is deeply appreciated, and I am confident that the team will draw on your insights to strengthen the implementation of the Guidelines’ recommendations in practice across different regions of the globe.
I am Heloísa Broggiato Matter, PhD. The inadequate access to opioides such as morphine, in Brazil is a result of a punitive approach in drug policy, restrictive regulations on internationally controlled medicines and challenges in the health system. Even if the Brazilian constitution recognizes the right to health, patients face many many adminstrative barriers to have access to such medicines. This creates stigma and unnecessary pain. The experience of countries with a drug policy respecting human rights, such as Germany, have a strong primary health care, able to manage severe pain and adopt a solid harm reduction practice. These two important aspects to achieve adequate access to controlled medicines and prevent opioid overdose deaths.
Dear Heloísa Broggiato Matter,
Thank you very much for sharing your thoughtful perspectives and reflections. Your contribution is highly valuable, and I would appreciate your guidance on a few practical points to help deepen our understanding:
How can UNDP better support inclusive, rights-based approaches to drug policy, particularly for marginalized or criminalized populations in Brazil?
What recommendations would you offer to strengthen UNDP’s work in this area?
How can UNDP and other UN partners ensure meaningful participation of affected communities in policy development and implementation?
Your insights on these questions would be extremely helpful as we work toward more effective and equitable approaches.